IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Frazier Life Sciences Management, L.P.

Q3 2024 Holdings

Filed 2024-11-15 | 53 holdings | $2.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$182.8M10,109,2797.3%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$213.4M12,855,1948.6%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$256.2M6,570,39210.3%
PreviousPage 2 of 2